Abstract

Anxiety is evoked by a threatening situation and display adaptive or defensive behaviors, found similarly in animals and humans. Neuropeptide Y (NPY) Y1 receptor (NPYY1R) and Galanin (GAL) receptor 2 (GALR2) interact in several regions of the limbic system, including the amygdala. In a previous study, GALR2 enhanced NPYY1R mediated anxiolytic actions on spatiotemporal parameters in the open field and elevated plus maze, involving the formation of GALR2/NPYY1R heteroreceptor complexes in the amygdala. Moreover, the inclusion of complementary ethological parameters provides a more comprehensive profile on the anxiolytic effects of a treatment. The purpose of the current study is to evaluate the anxiolytic effects and circuit activity modifications caused by coactivation of GALR2 and NPYY1R. Ethological measurements were performed in the open field, the elevated plus-maze and the light-dark box, together with immediate early gene expression analysis within the amygdala-hypothalamus-periaqueductal gray (PAG) axis, as well as in situ proximity ligation assay (PLA) to demonstrate the formation of GALR2/NPYY1R heteroreceptor complexes. GALR2 and NPYY1R coactivation resulted in anxiolytic behaviors such as increased rearing and head-dipping, reduced stretch attend postures and freezing compared to single agonist or aCSF injection. Neuronal activity indicated by cFos expression was decreased in the dorsolateral paracapsular intercalated (ITCp-dl) subregion of the amygdala, ventromedial hypothalamic (VMH) nucleus and ventrolateral part of the periaqueductal gray (vlPAG), while increased in the perifornical nucleus of the hypothalamus (PFX) following coactivation of GALR2 and NPYY1R. Moreover, an increased density of GALR2/NPYY1R heteroreceptor complexes was explicitly observed in ITCp-dl, following GALR2 and NPYY1R coactivation. Besides, knockdown of GALR2 was found to reduce the density of complexes in ITCp-dl. Taken together, these results open up the possibility that the increased anxiolytic activity demonstrated upon coactivation of NPYY1R and GALR2 receptor was related to actions on the ITCp-dl. GALR2-NPYY1R heteroreceptor complexes may inhibit neuronal activity, by also modifying the neuronal networks of the hypothalamus and the PAG. These results indicate that GALR2/NPYY1R interactions in medial paracapsular intercalated amygdala can provide a novel integrative mechanism in anxiolytic behavior and the basis for the development of heterobivalent agonist drugs targeting GALR2/NPYY1R heteromers, especially in the ITCp-dl of the amygdala for the treatment of anxiety.

Highlights

  • Anxiety is defined as a negative emotional state and defensive reaction characterized by a feeling of worries, apprehension, and uncertainty stemming from the anticipation of potential threats (Davis and Shi, 1999)

  • The current study confirms the existence of an interaction between Galanin Receptor 2 (GALR2) and NPY is primarily mediated by Y1 receptors (NPYY1R) seen upon combined receptor agonist treatment acting at these receptors

  • This GALR2 and NPYY1R coactivation elicited in innate models of anxiety a specific behavioral profile on ethological parameters, increasing rearing and head-dipping and reducing stretch attend postures and freezing, that strongly support anxiolytic actions

Read more

Summary

Introduction

Anxiety is defined as a negative emotional state and defensive reaction characterized by a feeling of worries, apprehension, and uncertainty stemming from the anticipation of potential threats (Davis and Shi, 1999). Humans and animals face an ambiguous threat stimulus and experience a high level of uncertainty and unpredictability (Lowry et al, 2005) This threatening situation evokes an evolutionarily conserved brain state which triggers adaptive or defensive behaviors, ranging from risk assessment and freezing to flight and defensive attack to avoid or reduce potential harm (Blanchard et al, 2001; LeDoux, 2012; Anderson and Adolphs, 2014). In the open-field, the elevated plus-maze and the light-dark box, main tests used for unconditioned anxiety (Prut and Belzung, 2003; Carobrez and Bertoglio, 2005; Treit et al, 2010) mice and rats show a spontaneous natural preference for unlit and protected spaces, and seem to avoid the open and/or lit areas. Reduced freezing or SAP was observed with anxiolytic drug treatments (Rey et al, 2012)

Objectives
Results
Conclusion

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.